ProKidney Corp. (PROK) SEC filings

PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30

$1.15+0.02 (+1.77%)

Close on Nov 12, 2026Market cap $347.67MP/E –Yield –

SEC filings

40 of ProKidney's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Nov 12, 2026	Nov 12, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2026	Nov 12, 2026	SEC EDGAR
Current report	8-K	Nov 9, 2026	Nov 9, 2026	SEC EDGAR
Current report	8-K	Oct 29, 2026	Oct 29, 2026	SEC EDGAR
Current report	8-K	Aug 10, 2026	Aug 10, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 10, 2026	SEC EDGAR
Current report	8-K	May 28, 2026	May 29, 2026	SEC EDGAR
Current report	8-K	May 15, 2026	May 15, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 15, 2026	SEC EDGAR
Proxy statement	DEF 14A	May 28, 2026	Apr 17, 2026	SEC EDGAR
Current report	8-K	Mar 18, 2026	Mar 18, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 18, 2026	SEC EDGAR
Current report	8-K	Feb 2, 2026	Feb 2, 2026	SEC EDGAR
Current report	8-K	Jan 12, 2026	Jan 12, 2026	SEC EDGAR
Current report	8-K	Nov 10, 2025	Nov 10, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 10, 2025	SEC EDGAR
Current report	8-K	Oct 17, 2025	Oct 17, 2025	SEC EDGAR
Current report	8-K	Aug 12, 2025	Aug 12, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 12, 2025	SEC EDGAR
Current report	8-K	Jul 15, 2025	Jul 15, 2025	SEC EDGAR
Current report	8-K	Jul 14, 2025	Jul 14, 2025	SEC EDGAR
Current report	8-K	Jul 8, 2025	Jul 8, 2025	SEC EDGAR
Current report	8-K	Jul 1, 2025	Jul 1, 2025	SEC EDGAR
Current report	8-K	May 29, 2025	May 30, 2025	SEC EDGAR
Current report	8-K	May 12, 2025	May 12, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 12, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Mar 17, 2025	SEC EDGAR
Current report	8-K	Mar 17, 2025	Mar 17, 2025	SEC EDGAR
Current report	8-K	Jan 17, 2025	Jan 21, 2025	SEC EDGAR
Current report	8-K	Nov 20, 2024	Nov 22, 2024	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 12, 2024	SEC EDGAR
Current report	8-K	Nov 12, 2024	Nov 12, 2024	SEC EDGAR
Current report	8-K	Sep 3, 2024	Sep 3, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 9, 2024	SEC EDGAR
Current report	8-K	Aug 9, 2024	Aug 9, 2024	SEC EDGAR
Current report	8-K	Jun 11, 2024	Jun 13, 2024	SEC EDGAR
Current report	8-K	Jun 10, 2024	Jun 10, 2024	SEC EDGAR
Current report	8-K	May 30, 2024	May 31, 2024	SEC EDGAR
Current report	8-K	May 29, 2024	May 29, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 10, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in ProKidney's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PROK.

Compare: PROK vs PLUR · PROK vs SABS · PROK vs LGVN · PROK vs IMA · PROK vs SCNI

Revenue growth4.2% · median -4.4%

Operating margin-24830.3% · median -2180.9%

Net margin-13326.7% · median -1932.8%

Company	Revenue	Growth
PLUR	$1.46M	+10.0%
LGVN	$1.17M	-18.9%
PROK	$775.00K	+4.2%
SABS	–	–
IMA	–	–
SCNI	–	–

Company

Next earnings (est.): Mar 17, 2027, during market hours
Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Fiscal year ends: December 31
Employees: 231
Held by institutions: 16.1%
Auditor: Ernst & Young LLP
SEC CIK: 1850270

Advertisement
300 × 250

See a number that looks wrong?